The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.47BCNY
663.20M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue (TTM)
626.64MCNY
93.07M · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
-196.46%
vs Aerospace & Defense peers
Updated Aug 19, 2026
Beta
-0.0510x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-34.97%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
4.47BCNY
663.20M · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
6.36BCNY
945.21M · vs all stocks (USD)
Updated Aug 19, 2026
Forward P/E
62.57x
vs Aerospace & Defense peers
Updated Aug 19, 2026
Price to Sales (TTM)
7.14x
vs Aerospace & Defense peers
Updated Aug 19, 2026
Price to Book (MRQ)
14.36x
vs Aerospace & Defense peers
Updated Aug 19, 2026
Enterprise to Revenue
10.16x
vs Aerospace & Defense peers
Updated Aug 19, 2026
Enterprise to EBITDA
-62.01x
vs Aerospace & Defense peers
Updated Aug 19, 2026
Gross Margin
13.57%
vs Aerospace & Defense peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -0.95%.Updated Aug 19, 2026
Profit Margin
-196.46%
vs Aerospace & Defense peers
Updated Aug 19, 2026
Operating Margin
-12.38%
vs Aerospace & Defense peers
Updated Aug 19, 2026
Return on Assets (TTM)
-3.72%
vs Aerospace & Defense peers
Updated Aug 19, 2026
Return on Equity (TTM)
-112.61%
vs Aerospace & Defense peers
Updated Aug 19, 2026
Revenue (TTM)
626.64MCNY
93.07M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
0.6060CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
-59.90%
vs Aerospace & Defense peers
Updated Aug 19, 2026
Gross Profit (TTM)
-5.94MCNY
-881.48K · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
-102.64MCNY
-15.24M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
-1.23BCNY
-182.85M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
-52.34%
vs Aerospace & Defense peers
Updated Aug 19, 2026
Operating Cash Flow (TTM)
-22.07MCNY
-3.28M · vs all stocks (USD)
Updated Aug 19, 2026
Payout Ratio
0.00%
vs Aerospace & Defense peers
Updated Aug 19, 2026
Minority Interest (Equity)
162.47MCNYFY2025 · Dec 31, 2025
Revenue
784.06MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
744.43MCNYFY2025 · Dec 31, 2025
Gross Profit
39.63MCNYFY2025 · Dec 31, 2025
Operating Income
-182.13MCNY
-27.05M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-1.24BCNYFY2025 · Dec 31, 2025
Income Tax Expense
-7.04MCNYFY2025 · Dec 31, 2025
Net Income
-1.24BCNYFY2025 · Dec 31, 2025
EBIT
-1.10BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-12.12MCNYFY2025 · Dec 31, 2025
Research & Development
61.48MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
47.56MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
18.46MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.31MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
140.72MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-1.20CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-1.20CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.02BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.02BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-1.24BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
7.02MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-976.15MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-994.81MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
86.04MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-1.24BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
146.24MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
50.03MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
63.33MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-18.66MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-5.50MCNYFY2025 · Dec 31, 2025
Sale of Investments
9.00MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-29.61MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-44.77MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.32BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.37BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-139.26MCNYFY2025 · Dec 31, 2025
Other Financing Charges
318.14MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
127.47MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.02BSharesUpdated Aug 19, 2026
Float Shares
995.23MSharesUpdated Aug 19, 2026
% Held by Insiders
16.51%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
3.13%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
230.26MCNY
34.20M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
0.2250CNYUpdated Aug 19, 2026
Total Debt (MRQ)
1.76BCNY
261.52M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
3.70x
vs Aerospace & Defense peers
Updated Aug 19, 2026
Current Ratio (MRQ)
0.8470x
vs Aerospace & Defense peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
0.3050CNYUpdated Aug 19, 2026
Total Assets
3.75BCNY
556.93M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.34BCNYFY2025 · Dec 31, 2025
Total Liabilities
3.25BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.41BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
492.17MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
2.76BCNYFY2025 · Dec 31, 2025
Cash
86.04MCNYFY2025 · Dec 31, 2025
Cash Equivalents
218.22MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
304.26MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
585.75KCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.25BCNYFY2025 · Dec 31, 2025
Inventory
473.06MCNYFY2025 · Dec 31, 2025
Accounts Payable
865.17MCNYFY2025 · Dec 31, 2025
Short-term Debt
1.34BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
276.43MCNYFY2025 · Dec 31, 2025
Long-term Debt
429.31MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
2.20MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.02BCNYFY2025 · Dec 31, 2025
Retained Earnings
-4.13BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
502.41MCNY
74.62M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
3.25CNYUpdated Aug 19, 2026
52-Week High
10.42CNYUpdated Aug 19, 2026
52-Week Change
-34.97%
vs all stocks
Updated Aug 19, 2026
Beta
-0.0510x
vs all stocks
Updated Aug 19, 2026
50-Day MA
4.04CNYUpdated Aug 19, 2026
200-Day MA
6.00CNYUpdated Aug 19, 2026
Avg 10-Day Volume
33.82MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
33.96MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
-1.20CNYUpdated Aug 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is -196.5%, lower than 95% of its Aerospace & Defense peers (median 6.8%)Significant